A critical advance in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This essential malignant protector protein is frequently disabled in several kinds of cancer, resulting https://bookmarkingbay.com/story21918109/nanobodies-restore-p53-the-new-pathway-for-malignant-management